NHS reveals plans to increase hospital services
NHS England have issued a plan for re-instating urgent and [...]
Challenges of early detection of renal cell carcinoma
The incidence of kidney cancer in the UK has risen [...]
Ilixadencel granted Regenerative Medicine Advanced Therapy by FDA for metastatic kidney cancer
The US Food and Drug Administration (FDA) has designated ilixadencel [...]
Phase 1 trial of vorolanib plus everolimus for advanced kidney cancer
A new combination of vorolanib, a tyrosine kinase inhibitor plus [...]
Patients with cancer seem more vulnerable to COVID-19
A study conducted at Wuhan Hospital in China has shown [...]
Impact of lymph-node positive kidney cancer on survival
A recent study published in the journal Cancer last month [...]
Patient-reported outcomes with atezolizumab plus bevacizumab in metastatic kidney cancer
This study describes patient-reported outcomes from the phase 3 IMmotion151 [...]
My husband has kidney cancer but still not considered vulnerable
A recent letter in Metro highlights the difficulties facing cancer [...]
How GP practices should support shielded patients during the COVID-19 outbreak
Patients who are most at risk of severe complications from [...]
Coronavirus outbreak FAQs: what you can and can’t do
The government have issued a set of frequently asked questions [...]
